These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8298582)

  • 1. Signal transduction pathways: new targets in oncology.
    Sweeb RK; Beijnen JH
    Pharm World Sci; 1993 Dec; 15(6):233-42. PubMed ID: 8298582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling pathways as targets for anticancer drug development.
    Powis G
    Pharmacol Ther; 1994; 62(1-2):57-95. PubMed ID: 7991648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling targets for anticancer drug development.
    Powis G
    Trends Pharmacol Sci; 1991 May; 12(5):188-94. PubMed ID: 1862534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of phospholipid intracellular signaling as antiproliferative agents.
    Powis G; Hill SR; Frew TJ; Sherrill KW
    Med Res Rev; 1995 Mar; 15(2):121-38. PubMed ID: 7739293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the development of anticancer drugs that act against signalling pathways.
    Powis G
    Tumori; 1994 Apr; 80(2):69-87. PubMed ID: 8016910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
    Favoni RE; de Cupis A
    Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing time for cancer cells.
    Klein S; McCormick F; Levitzki A
    Nat Rev Cancer; 2005 Jul; 5(7):573-80. PubMed ID: 15965492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor and oncogene signalling pathways as targets for rational anticancer drug development.
    Powis G; Kozikowski A
    Clin Biochem; 1991 Oct; 24(5):385-97. PubMed ID: 1760877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of phosphatidylinositol signalling as antiproliferative agents.
    Powis G; Phil D
    Cancer Metastasis Rev; 1994 Mar; 13(1):91-103. PubMed ID: 8143348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
    Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
    Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting new anticancer drugs within signalling pathways regulated by the Ras GTPase superfamily (Review).
    Ramírez De Molina A; Rodríguez-González A; Lacal JC
    Int J Oncol; 2001 Jul; 19(1):5-17. PubMed ID: 11408916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.
    Zhang J; Chen YH; Lu Q
    Future Oncol; 2010 Apr; 6(4):587-603. PubMed ID: 20373871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
    Hartog H; Wesseling J; Boezen HM; van der Graaf WT
    Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell signalling pathways.
    Langdon SP; Smyth JF
    Cancer Treat Rev; 1995 Jan; 21(1):65-89. PubMed ID: 7859227
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in the study of antitumor drug targeting on the Ras signaling pathway].
    Zhu YJ; Jiang FC
    Yao Xue Xue Bao; 2009 Jan; 44(1):1-10. PubMed ID: 19350814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting RAS signalling pathways in cancer therapy.
    Downward J
    Nat Rev Cancer; 2003 Jan; 3(1):11-22. PubMed ID: 12509763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO Signaling Pathways as Therapeutic Targets in Cancer.
    Farhan M; Wang H; Gaur U; Little PJ; Xu J; Zheng W
    Int J Biol Sci; 2017; 13(7):815-827. PubMed ID: 28808415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues.
    Christoffersen T; Guren TK; Spindler KL; Dahl O; Lønning PE; Gjertsen BT
    Eur J Pharmacol; 2009 Dec; 625(1-3):6-22. PubMed ID: 19836383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.